Catalyst Wire Dossier Catalyst Wire Dossier

Idursulfase (intrathecal administration)

idursulfase · Shire
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Idursulfase (intrathecal administration), covering 2014-05-16 to 2014-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® [Phase 1, Phase 2]

See pricing